Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Guilherme H Oliveira, MD, is a staff cardiologist in the Section of Heart Failure and Cardiac Transplant Medicine in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute. He is board-certified in internal medicine and cardiovascular disease.
Dr. Oliveira specializes in the diagnosis and management of cardiomyopathies and advanced heart failure therapies such as heart transplants and mechanical circulatory support. In addition, Dr. Oliveira is an expert in cardio-oncology, preventing and treating cardiovascular complications of cancer therapies.
Dr. Oliveira was named to the Cleveland Clinic staff in 2010. Prior to his appointment he was Assistant Professor in the Department of Cardiology, University of Texas MD Anderson Cancer Center and Instructor of Medicine in the Department of Internal Medicine at Mayo Clinic College of Medicine. He was a 2010 finalist of the James S. and Suzanne Cyrus Scholar Award for Clinical Research, Division of Internal Medicine at MD Anderson. His other previous positions include private cardiologist at Henlopen Cardiology and Beebe Medical Center, Rehoboth Beach, Delaware, and associate staff at Hospital Barra D'Or in Rio de Janeiro, Brazil.
Dr. Oliveira is a graduate of the Faculdade Nacional De Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. He served his residency in internal medicine at the Hospital Universitario Clementino Fraga Filho and a second internal medicine residency at Mayo Clinic Rochester, during which he earned the Mayo Clinic Internal Medicine Residency Outstanding Research Award.
After completing his residency at Mayo Clinic, Dr Oliveira served a fellowship in cardiology at Baylor College of Medicine in Houston followed by a fellowship in advanced heart failure and transplant at Baylor and Methodist DeBakey Heart Center. While at Baylor he received the 2005 Jay N. Cohn New Investigator Award from the Heart Failure Society of America.
Dr. Oliveira has published more than three dozen peer-reviewed original research articles and abstracts, ten chapters in medical textbooks and is Editor-in-Chief of the Mayo Clinic Medical Manual. He is an editorial reviewer for the American Journal of Cardiology, Nature Reviews Clinical Oncology, Journal of Cardiac Failure, PLOS one and Cancer Journal. A frequent lecturer and invited speaker, he has made presentations at numerous national and international scientific meetings, including the prestigious American Society of Nuclear Cardiology, American College of Cardiology Annual Scientific Sessions and American Heart Association Annual Session.
Dr. Oliveira is a member of the American College of Cardiology, American Heart Association, American Medical Association, American College of Physicians, International Society for Heart and Lung Transplantation, Heart Failure Society of America, Sociedad Interamericana de Cardiologia and Sociedade Brasileira de Cardiologia.
Cancer heart disease, amyloidosis, cardiomyopathy, cardiac tumors, heart failure, heart transplantation, ventricular assist device, myocardial biopsy, cardiac catheterization
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/1/2012, Dr. Oliveira has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.